(Q33560160)

28 July 2017

1 reference

title

Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection (English)

1 reference

28 July 2017

1 reference

1 reference

1 reference

Holliday SM

1

1 reference

PubMed ID

10146907

28 July 2017

Faulds D

series ordinal

2

1 reference

28 July 2017

1 February 1994

1 reference

28 July 2017

1 reference

28 July 2017

5

1 reference

28 July 2017

2

1 reference

28 July 2017

141-171

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-199405020-00008

28 July 2017

0 references

cites work

A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis

1 reference

12 December 2020

Pharmacoeconomics of immunisation: a review

1 reference

12 December 2020

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

12 December 2020

Cost effectiveness of antenatal hepatitis B screening and vaccination of infants

1 reference

12 December 2020

Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis

1 reference

12 December 2020

Routine screening for hepatitis B in an obstetric population

1 reference

12 December 2020

Hepatitis B Vaccine in Pregnancy: Maternal and Fetal Safety

1 reference

12 December 2020

Prevention of acute and chronic liver disease through immunization: hepatitis B and beyond

1 reference

12 December 2020

Hepatitis B infection in the United States. Recent trends and future strategies for control

1 reference

12 December 2020

Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization

1 reference

12 December 2020

Routine hepatitis screening in adolescent pregnancies: is it cost effective?

1 reference

12 December 2020

Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity

1 reference

12 December 2020

Hepatitis B screening and immunization for people with a mental handicap in Southampton: costs and benefits

1 reference

12 December 2020

Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity

1 reference

12 December 2020

Should all pregnant women be screened for hepatitis B surface antigen?

1 reference

12 December 2020

National advisory committee on immunization (NACI). Statement on hepatitis B vaccine

1 reference

12 December 2020

The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies

1 reference

12 December 2020

Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons

1 reference

12 December 2020

Low-dose intradermal and intramuscular vaccination against hepatitis B

1 reference

12 December 2020

Hepatitis B: Evolving Epidemiology and Implications for Control

1 reference

12 December 2020

Hepatitis B virus vaccine. Cost-benefit analysis of its use in a children's hospital

1 reference

12 December 2020

Immunization against hepatitis B: report on a WHO meeting on viral hepatitis in Europe

1 reference

12 December 2020

Viral hepatitis vaccines

1 reference

12 December 2020

Cost-effectiveness of prenatal screening and immunization for hepatitis B virus

1 reference

12 December 2020

Strategies for immunization against hepatitis B in western Europe

1 reference

12 December 2020

Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study

1 reference

12 December 2020

Overview of clinical studies with hepatitis B vaccine made by recombinant DNA

1 reference

12 December 2020

Leads from the MMWR. Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen

1 reference

12 December 2020

Immunization against hepatitis B.

1 reference

12 December 2020

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

1 reference

12 December 2020

Scheduling of revaccination against hepatitis B virus

1 reference

12 December 2020

Cost-benefit analysis of hepatitis-B vaccination

1 reference

12 December 2020

Controversies in immunization against hepatitis B

1 reference

12 December 2020

Effectiveness of intradermal hepatitis B immunization of hospital staff

1 reference

12 December 2020

Trials of intradermal hepatitis B vaccines in Gambian children

1 reference

12 December 2020

Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial.

1 reference

12 December 2020

Cost-benefit analysis of the introduction of mass vaccination against hepatitis B in Italy

1 reference

12 December 2020

Screening for HBsAg in pregnant women: a cost analysis of the universal screening policy in the province of Quebec

1 reference

12 December 2020

Cost-effectiveness analysis of prenatal screening and vaccination against hepatitis B virus--the case of Belgium

1 reference

12 December 2020

A scale of valuations of states of illness: is there a social consensus?

1 reference

12 December 2020

Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years

1 reference

12 December 2020

Hepatitis B vaccination with short dose intervals--a possible alternative for post-exposure prophylaxis?

1 reference

12 December 2020

Routine childhood immunisation: is it worth it?

1 reference

12 December 2020

Cost effectiveness of screening for only anti-HBc in institutions for mentally retarded persons

1 reference

12 December 2020

Universal prenatal hepatitis B testing: is it cost-effective?

1 reference

12 December 2020

Control of hepatitis B through routine immunization of infants: the need for flexible schedules and new combination vaccine formulations

1 reference

12 December 2020

Principles of pharmacoeconomic analysis of drug therapy

1 reference

12 December 2020

Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies

1 reference

12 December 2020

Benefit-Cost Analysis of Hepatitis B Vaccine Programs for Occupationally Exposed Workers

1 reference

12 December 2020

Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program

1 reference

12 December 2020

Cost-effectiveness of hepatitis B screening in a mental health institution.

1 reference

12 December 2020

Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine.

1 reference

12 December 2020

1 reference

12 December 2020

Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers

1 reference

12 December 2020

Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma

1 reference

12 December 2020

HBV pre-vaccination screening in hospital personnel: cost-effectiveness analysis

1 reference

12 December 2020

Should all pregnant women be screened for hepatitis B?

1 reference

12 December 2020

Hepatitis B vaccine and hepatitis B markers: cost effectiveness of screening prehospital personnel

1 reference

12 December 2020

Cost-Benefit Analysis of Hepatitis-B Vaccination: A Computerized Decision Model for Spain

1 reference

12 December 2020

Cost-effectiveness study of prevaccination screening tests in vaccination against hepatitis B in hospital health professionals

1 reference

12 December 2020

Cost-Effectiveness of Hepatitis-B Vaccine in Greece: A Country of Intermediate HBV Endemicity

1 reference

12 December 2020

Current thoughts on the risks and benefits of immunisation

1 reference

12 December 2020

Development of recommendations for control of hepatitis B virus infections: the role of cost analysis

1 reference

12 December 2020

A cost comparison analysis for screening and vaccination of hospital personnel with high- and low-prevalence hepatitis B virus antibodies in California

1 reference

12 December 2020

Hepatitis B virus. The major etiology of hepatocellular carcinoma

1 reference

12 December 2020

Hepatitis B immunization strategies: expanding the target

1 reference

12 December 2020

Immunization against hepatitis B.

1 reference

12 December 2020

Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection

1 reference

12 December 2020

Epidemiology of hepatitis B

1 reference

12 December 2020

Cost of plasma-derived hepatitis B vaccine production.

1 reference

12 December 2020

A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates

1 reference

12 December 2020

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

12 December 2020

Cost-benefit analysis of hepatitis B vaccination

1 reference

12 December 2020

Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)

1 reference

12 December 2020

Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment

1 reference

12 December 2020

Hepatitis B: global importance and need for control

1 reference

12 December 2020

Notification of viral hepatitis

1 reference

12 December 2020

10.2165/00019053-199405020-00008

Identifiers

DOI

1 reference

PubMed ID

10146907

Dimensions Publication ID

28 July 2017

0 references

1 reference

PubMed ID

10146907